BBLGW
Price:
$32.24
Market Cap:
$2.70M
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a...[Read more]
Industry
Medical - Devices
IPO Date
2021-10-13
Stock Exchange
NASDAQ
Ticker
BBLGW
According to Bone Biologics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -223.89. This represents a change of 58.32% compared to the average of -0.38 of the last 4 quarters.
The mean historical PE Ratio of Bone Biologics Corporation over the last ten years is -64.12. The current -223.89 PE Ratio has changed 34.82% with respect to the historical average. Over the past ten years (40 quarters), BBLGW's PE Ratio was at its highest in in the June 2017 quarter at 303.89. The PE Ratio was at its lowest in in the June 2022 quarter at -1854.51.
Average
-64.12
Median
-17.63
Minimum
-238.80
Maximum
3.45
Discovering the peaks and valleys of Bone Biologics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 525.42%
Maximum Annual PE Ratio = 3.45
Minimum Annual Increase = -134.68%
Minimum Annual PE Ratio = -238.80
Year | PE Ratio | Change |
---|---|---|
2023 | -0.13 | -103.86% |
2022 | 3.45 | -134.68% |
2021 | -9.94 | -48.69% |
2020 | -19.36 | 87.37% |
2019 | -10.33 | -94.37% |
2018 | -183.50 | 84.64% |
2017 | -99.38 | 525.42% |
2016 | -15.89 | -76.38% |
2015 | -67.27 | -71.83% |
2014 | -238.80 | -99.79% |
The current PE Ratio of Bone Biologics Corporation (BBLGW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.21
5-year avg
-7.26
10-year avg
-64.12
Bone Biologics Corporation’s PE Ratio is less than Bone Biologics Corporation (-0.29), less than Biofrontera Inc. (-0.38), less than Inspira Technologies Oxy B.H.N. Ltd. (-2.45), less than PetVivo Holdings, Inc. (-0.92), less than Pasithea Therapeutics Corp. (-0.23),
Company | PE Ratio | Market cap |
---|---|---|
-0.29 | $2.70M | |
-0.38 | $7.35M | |
-2.45 | $22.70M | |
-0.92 | $401.06K | |
-0.23 | $3.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bone Biologics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bone Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bone Biologics Corporation's PE Ratio?
How is the PE Ratio calculated for Bone Biologics Corporation (BBLGW)?
What is the highest PE Ratio for Bone Biologics Corporation (BBLGW)?
What is the 3-year average PE Ratio for Bone Biologics Corporation (BBLGW)?
What is the 5-year average PE Ratio for Bone Biologics Corporation (BBLGW)?
How does the current PE Ratio for Bone Biologics Corporation (BBLGW) compare to its historical average?